# Axel Heidenreich

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/axel-heidenreich/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,933 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 92 |
| i10-index | 416 |
| Last Known Institution | Klinik und Poliklinik für Urologie |
| OpenAlex ID | https://openalex.org/A5048118430 |
| ORCID iD | https://orcid.org/0000-0002-2511-3664 |
| Works | 1,463 |

## Researcher papers

- [Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-the-report-of-the-advanced/)
- [ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder](https://scholariq.org/papers/icud-eau-international-consultation-on-bladder-cancer-2012-radical-cystectomy/)
- [Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/addition-of-radium-223-to-abiraterone-acetate-and-prednisone-or-prednisolone-in/)
- [Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-report-of-the-advanced/)
- [Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer](https://scholariq.org/papers/randomized-open-label-phase-iii-trial-of-docetaxel-plus-high-dose-calcitriol/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Testicular diseases and treatments](https://scholariq.org/topics/testicular-diseases-and-treatments-2/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Urologic and reproductive health conditions](https://scholariq.org/topics/urologic-and-reproductive-health-conditions-2/)

## Researcher university

- [Klinik und Poliklinik für Urologie](https://scholariq.org/institutions/klinik-und-poliklinik-fur-urologie/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.